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Almost all bacteria possess glutamate racemase to
synthesize D-glutamate as an essential component of
peptidoglycans in the cell walls. The enforced produc-
tion of glutamate racemase, however, resulted in sup-
pression of cell proliferation. In the Escherichia coli
JM109/pGR3 clone, the overproducer of glutamate race-
mase, the copy number (i.e. replication efficiency) of
plasmid DNA declined dramatically, whereas the E. coli
WM335 mutant that is defective in the gene of glutamate
racemase showed little genetic competency. The com-
paratively low and high activities for DNA supercoiling
were contained in the E. coli JM109/pGR3 and WM335
cells, respectively. Furthermore, we found that the DNA
gyrase of E. coli was modulated by the glutamate race-
mase of E. coli in the presence of UDP-N-acetylmuramyl-
L-alanine, which is a peptidoglycan precursor and func-
tions as an absolute activator for the racemase. This is
the first finding of the enzyme protein participating in
both D-amino acid metabolism and DNA processing.
Bacterial cell walls contain D-amino acids as essential com-
ponents of peptidoglycans (alternatively, mureins). D-Gluta-
mate is introduced into peptidoglycan through its addition to
UDP-N-acetylmuramyl-L-alanine (UDP-MurNAc-L-Ala),1 a
peptidoglycan precursor, by UDP-MurNAc-L-Ala:D-glutamate
ligase (EC 6.3.2.9). Glutamate racemase (EC 5.1.1.3) catalyzes
the racemization of glutamate (1). The genes encoding gluta-
mate racemase are ubiquitously inherited in bacteria, and the
Escherichia coli WM335 mutant, in which the enzyme gene
was disrupted, required D-glutamate for growth (2). These find-
ings indicate that glutamate racemase provides D-glutamate
for peptidoglycan synthesis. Glutamate racemase and its gene
hereafter are designated MurI and murI, respectively.
The activity of glutamate racemase, however, usually cannot
be detected in the cells of bacteria, except in a part of lactoba-
cilli and bacilli (3). Doublet et al. (4) showed that MurI of E. coli
catalyzed the glutamate racemization only in the presence of
UDP-MurNAc-L-Ala and concluded that this peptidoglycan pre-
cursor is an absolute activator of the MurI enzyme. On the
other hand, the fact that no ribosome-binding sequence is found
upstream of the open reading frames in the murI genes of
various bacteria and the initial codon of the open reading
frames often includes the substitution of the usual ATG for the
unusual TTG or GTG (5, 6) suggests that the murI gene is
translated on a specific mechanism that is still unidentified. It
is generally assumed that MurI is strictly controlled so as to
operate only during peptidoglycan synthesis (eventually during
cell division). In E. coli clones, the enforced production of MurIs
resulted in characteristic changes, such as aberration in nucle-
oid separation (7) and suppression of cell proliferation (6, 7),
indicating that the attenuation of murI gene expression and
the regulation of MurI production are physiologically signifi-
cant. In the absence of D-glutamate, the cells of the E. coli
WM335 mutant formed filament elongates (2), as did the mu-
tants defective in the genes involved in cell division. These
observations imply that MurI plays a role in cell homeostasis
other than in the D-glutamate supply. However, there have
been surprisingly few examples focusing on the multifunction-
ality of MurI until now. In this study, the in vivo and in vitro
effects of MurI on some DNA processing in E. coli were inves-
tigated. Here we report the novel function of glutamate race-
mase, i.e. the modulation of DNA gyrase activity.
EXPERIMENTAL PROCEDURES
Materials—Supercoiled pBR322, calf thymus DNA topoisomerase I,
and isopropyl--D-thiogalactopyranoside (IPTG) were purchased from
TaKaRa Shuzo. Relaxed pBR322 was prepared from supercoiled
pBR322 with the DNA topoisomerase I by the method of Ferro and
Olivera (8). UDP-MurNAc-L-Ala was prepared from the cell extract of E.
coli WM335 according to the method described previously (6). A novo-
biocin-Sepharose resin was prepared by the method of Nakanishi et al.
(9). All other chemicals were of analytical grade.
Bacteria—E. coli JM109 was purchased from TaKaRa Shuzo. E. coli
WM335 mutant was a kind gift from Prof. Dr. W. Messer of the Max
Planck Institute for Molecular Genetics.
Vector Plasmids—Vector plasmids pKK223-3 and pTrc99A, both of
which contain an ampicillin (Amp) resistance gene, were obtained from
Amersham Biosciences, and pACYC184 that carries a tetracycline (Tet)
resistance gene was from Nippon Gene. Both plasmids pGR2 and pGR3
were constructed according to the strategy described previously (5) and
used for analysis of the function of glutamate racemase. For the pro-
duction of E. coli DNA gyrase (GyrAB), plasmid pGYRA, a pTrc99A
having the gyrA gene, and plasmid pGYRB, a pTrc99A having the gyrB
gene, were designed by the method of Mizuuchi et al. (10). To obtain E.
coli DNA toposiomerase IV (ParCE), plasmid pPARC, a pTrc99A having
the perC gene, and plasmid pPARE, a pTrc99A having the parE gene,
were prepared by the method of Kato et al. (11).
Transformation—E. coli cells were transformed with the vector plas-
mid DNA by the CaCl2 method (12) or the TSS method (13) and grown
on the LB media containing appropriate antibiotics (1, 12).
Measurement of Plasmid Copy Number—Plasmid copy numbers
were determined densitometrically with a Digital Science EDAS 120 LE
system (Invitrogen) by the method of Projan et al. (14).
Enzyme Assays—Glutamate racemase was assayed by the method
described previously (3). One unit of MurI was defined as the amount of
enzyme that catalyzed the formation of 1 mol of L-glutamate per min.
DNA gyrase was assayed as follows. The reaction mixture (20 l)
comprised 2 mol of Tris-HCl (pH 8.0), 1.4 mol of KCl, 0.2 mol of
MgCl2, 0.1 mol of ATP, 0.1 mol of spermidine hydrochloride, 0.1 mol
of dithiothreitol, 2 nmol of EDTA, 0.2 mg of glycerol, 0.5 g of relaxed
pBR322, and enzyme. The enzyme was replaced with water in a blank.
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The reaction was essentially performed at 37 °C for 1 h and terminated
by the phenol-chloroform extraction (12). The reaction mixture was
electrophoresed in 1% (w/v) agarose gel (14 14 cm) submerged in TPE
buffer (90 mM Tris-phosphate, 2 mM EDTA, pH 8.0) at 4 V/cm at 25 °C
for 2.5 h. Gel was stained with ethidium bromide (1 g/ml). The activity
was estimated from both an increase in the density of bands correspond-
ing to the supercoiled DNA thus formed (10) and a decrease in that of
the relaxed DNA substrate, which were quantitated with the Digital
Science EDAS 120 LE system. One unit of GyrAB was defined as the
amount of enzyme that converted one-half of relaxed pBR322 into the
supercoils per 30 min.
DNA topoisomerases I (TopA) and IV (ParCE) were assayed in the
absence (15) and the presence of ATP (11), respectively. One unit of both
topoisomerases was defined as the amount of enzyme required to fully
relax 0.5 g of supercoiled pBR322 per h.
Enzymes—E. coli MurI was purified by the method described previ-
ously (1). The specific activity was 9.6 units mg1. Protein concentra-
tions were determined spectrophotometrically using its theoretical mo-
lar extinction (278  22,280 M
1 cm1) (1, 4).
Since overproduction of DNA gyrase into an active form, i.e. a
GyrA2B2 heterotetramer (molecular mass, 373,767 Da), results in
strong inhibition of cell growth in bacteria, E. coli GyrAB was prepared
by reconstitution of the A subunit (GyrA, 96,975 Da) and the B subunit
(GyrB, 89,893 Da) (10). Cell lyses with lysozyme and Brij-58, removal of
the DNA extracted with streptomycin, and precipitation of proteins
with ammonium sulfate were conducted according to the method of
Nakanishi et al. (9). The GyrA preparation from E. coli JM109/pGYRA
cells (110 mg of protein) was applied to a Bio-Rad Bio-Logic FPLC
system equipped with a Bio-Scale DEAE anion-exchange column (vol-
ume, 20 ml; Bio-Rad) (3); the fraction eluted with 0.4 M NaCl contained
only the GyrA protein. The GyrB preparation from E. coli JM109/
pGYRB cells (88 mg of protein) was subjected to affinity chromatogra-
phy on a novobiocin-Sepharose column (1.5 7 cm; volume, 12.5 ml) (9);
the fraction eluted with 2 M KCl plus 5 M urea contained only the GyrB
protein. The enzyme was reconstituted by incubation of the purified
GyrA and GyrB at an equimolar ratio at 25 °C for 30 min in the
presence of 0.1 mM ATP. The specific activity was 3.8  104 units mg1.
Protein concentrations were determined using its theoretical molar
extinction (278  248,200 M
1 cm1) (10).
E. coli ParCE was purified by the method of Kato et al. (11). The
specific activity was 3.3  103 units mg1. Protein concentrations were
determined using its theoretical molar extinction (278  229,920 M
1
cm1) (11).
RESULTS
Effects on Plasmid Copy Number—To examine whether the
production of MurI affects DNA processing in E. coli, we first
assayed the plasmid copy numbers in several E. coli clones. In
this experiment, both plasmid pGR2, a pKK223-3 having the
murI gene isolated from the E. coli chromosome, and plasmid
pGR3, a pKK223-3 having the designed murI gene in which a
typical ribosome-binding sequence was introduced (5), were
used. The plasmid pKK223-3, the multiplication of which is
entirely dependent on the replication machineries of the host
cells, i.e. the  mechanism (16), was used as a control (usually
over 20 copies). As shown in Fig. 1, the enforced production of
MurI by the use of the plasmid pGR3 resulted in a dramatic
decrease in the copy numbers in both E. coli JM109 and
WM335 clone cells (one to several copies). The result also
showed that a decreased plasmid copy number in the E. coli
WM335 mutant was restored by complementation of the native
murI gene with the plasmid pGR2. A decline in negative su-
perhelicity of the plasmid in the MurI overproducer, E. coli
JM109/pGR3, but not of those in E. coli JM109/pKK223–3
and JM109/pGR2 was observed by the use of chloroquine
(data not shown), and this was consistent with what Baliko´
and Venetianer (7) had proposed. It thus seems likely that
the replication of ColE1-type plasmids such as pKK223-3 is
difficult to complete properly in E. coli cells exhibiting aber-
ration of the production of MurI due to deficiency in the
controls of DNA superhelical density (11). MurI would also
influence the replication of chromosome, since the overex-
pression and disruption of the murI gene allowed the appear-
ance of abnormal cell growth in E. coli (2, 6, 7).
Effects on Genetic Competence—While examining character-
istics of the E. coli WM335 mutant, we found that its genetic
competence declined dramatically compared with that of E. coli
JM109, which has an intact murI gene, and, further, that such
a decline in genetic competence of the mutant was recovered by
the complementation of the murI gene with the plasmid pGR2
(Table I). Chandler and Smith (17) recently reported that, in
bacteria, TopA catalyzing the reverse of the DNA gyrase reac-
tion was essential for the development of genetic competence.
The relationship between the development of the genetic com-
petence and the intracellular activity for DNA supercoiling was
demonstrated. Our results indicated that MurI affects the in-
tracellular activity for DNA supercoiling.
Effects on DNA Supercoiling Activities—The intracellular
activity for DNA supercoiling was practically determined in the
balance of the activities of TopA and GyrAB (18), and net DNA
supercoiling activity of bacterial cells can be determined by
using the DNA gyrase assay system because the cell extracts
essentially contain both the activities of GyrAB, which intro-
duces negative supercoils into DNAs, and of TopA, which un-
winds the supercoiled DNAs. In this study, comparatively low
and high DNA supercoiling activities were observed in the cells
of E. coli JM109/pGR3 and WM335, respectively (Fig. 2). The
supercoiling activity of E. coli JM109/pGR3 cells was one-tenth
that of E. coli JM109/pKK223-3 cells; the intracellular activi-
ties of E. coli WM335 and E. coli WM335/pGR3 were 2-fold
higher and 4-fold less than that of E. coli WM335/pGR2, re-
spectively. In contrast, there was apparently little difference in
the activities of TopA among the E. coli clones used: JM109/
pKK223-3, 31  7 (units mg1); JM109/pGR2, 34  12; JM109/
pGR3, 39  14; WM335/pKK223-3, 28  13; WM335/pGR2,
30  5; WM335/pGR3, 33  6. It was thus suggested that MurI
affects the intracellular activity of GyrAB in E. coli.
Inhibition of DNA Gyrase by Glutamate Racemase—To clar-
ify if MurI modulates GyrAB, we followed a change in the
apparent activity of GyrAB in the coexistence of various con-
centrations of MurI. Bovine serum albumin, instead of E. coli
FIG. 1. Effects of the enforced production of glutamate race-
mase on the plasmid copy number in E. coli cells. A, the plasmid
copy numbers of each E. coli JM109 clone harboring pKK223-3 (empty
vector), pGR2 (vector carrying the murI gene from E. coli), or pGR3
(vector for enforced expression of the murI gene (5)). B, the plasmid copy
numbers of each E. coli WM335 clone harboring pKK223-3, pGR2, or
pGR3. These E. coli clones were cultivated at 37 °C in 10 ml of the
D-glutamate-LB broth (2) containing Amp (50 g/ml) and IPTG (1 mM)
until the turbidity at 600 nm of the culture broth reached 2.1. The whole
DNA was isolated by the method of Saito and Miura (21), and the
plasmid DNA was prepared by the alkali-SDS method (12). The plasmid
copy number was defined to be 1 when 1 ng of the plasmid DNA was
contained in 1 g of the whole DNA on the basis of the difference in
molecular sizes between the plasmid DNA used and the chromosomal
DNA of E. coli. Data are representative as means  S.E. of eight
independent experiments.
A Novel Function of Glutamate Racemase 39071
 at KO
CHI UNIVERSITY, on Novem
ber 12, 2009
w
w
w
.jbc.org
D
ow
nloaded from
 
MurI, was added to the DNA gyrase assay system as a negative
control (Fig. 3, open diamonds). As shown in Fig. 3A, GyrAB
was inhibited by E. coli MurI in the presence of UDP-MurNAc-
L-Ala (closed circles) but not both enantiomers of glutamate
(open triangles and open squares). Fig. 3A also reveals that
GyrAB probably forms a 1:1 molar stoichiometric inactive com-
plex with MurI activated by UDP-MurNAc-L-Ala. The apparent
inhibition constant Ki(app) of MurI against GyrAB was esti-
mated to be 6.8 nM (Fig. 3B) On the other hand, E. coli MurI
(0.5 nM) kept the activity of glutamate racemase even in the
presence of a 250-fold molar excess of GyrAB.
Effect of Glutamate Racemase on the Activity of DNA Topo-
isomerase IV—ParCE, a GyrAB paralogue, participates in the
chromosome partitioning (11) that occurs after the DNA repli-
cation in cell division. The enzyme (20 nM), however, remained
active when coexisting with abundant MurI (125 nM). These
suggest that DNA gyrase is the target of glutamate racemase in
E. coli.
DISCUSSION
DNA gyrase (alternatively, bacterial DNA topoisomerase II)
is a pivotal enzyme for various types of DNA processing, in-
cluding DNA replication and gene expression, and the strict
modulation of the intracellular activity is indispensable for
proper cell division (10). The first endogenous DNA gyrase
modulator, designated as GyrI (9), was identified from E. coli;
it was identical to the SbmC protein, which had been previ-
ously characterized as a member of the DNA repair system.
Because glutamate racemase, however, has been classified into
the group of D-amino acid-metabolic enzymes but not into that
of DNA-processing proteins, such as the GyrI protein, and does
not have any consensus sequences that can be observed in the
DNA-binding motifs (3, 5, 6), the discovery of the novel function
of glutamate racemase as the endogenous inhibitor for DNA
gyrase was quite unexpected. Nevertheless, the existence of
such multifunctional glutamate racemases would be advanta-
geous in the peculiar processes seen only during bacterial cell
division, in which the synthesis of the peptidoglycan molecules
(as an essential constituent of the septum and cell walls) fol-
lows DNA processing (e.g. the decatenation of daughter DNAs
catalyzed by DNA gyrase) (11), for example.
In bacterial glutamate racemases, E. coli MurI is functionally
particular; it is led into an active form by UDP-MurNAc-L-Ala (4).
E. coli MurI thus operates only during the peptidoglycan synthe-
sis and changes again into an inactive form with exhaustion of
UDP-MurNAc-L-Ala after peptidoglycan synthesis. As shown in
Fig. 3A, UDP-MurNAc-L-Ala was essential for the inhibition of
GyrAB by E. coli MurI, suggesting that the function of DNA
gyrase is suppressed by glutamate racemase at the early stage of
the septation in E. coli cells. It seems likely that this step is
important to avoid the appearances of abnormal DNA replication
and decatenation due to excessive DNA gyrase activity. We have
identified the glutamate racemase isozyme of Bacillus subtilis,
YrpC (lately B. subtilis MurI), which was not modulated by
UDP-MurNAc-L-Ala (6). Unlike E. coli MurI, B. subtilis MurI,
whether coexisting with UDP-MurNAc-L-Ala or not, inhibited
DNA gyrase.2 Although Doublet et al. (4) previously mentioned a
toxicity of D-glutamate produced by glutamate racemase on the
2 M. Ashiuchi, E. Kuwana, K. Komatsu, K. Soda, and H. Misono,
manuscript in preparation.
TABLE I
Competency of E. coli WM335 mutant defective in the
glutamate racemase gene
E. coli JM109 transformants with pKK223–3 or pACYC184, E. coli
WM335 transformants with pKK223–3 or pACYC184, and both E. coli
JM109/pGR2 and WM335/pGR2 transformants with pACYC184 were
grown at 37 °C for 24 h on an LB plate (12) containing Amp (50 g/ml)
or Tet (12.5 g/ml), a D-glutamate-LB plate (2) containing Amp or Tet,
and an LB plate containing Amp, Tet, and 0.1 mM IPTG, respectively.
Competency of each E. coli recipient was assessed on the basis of the
number of colonies being formed. Data are representative of an average
of eight independent experiments.
E. coli
recipients Vectors
a
Competency
CaCl2
b TSSc
JM109 pKK223–3 7.8  103 1.2  105
pACYC184 4.0  103 9.2  104
WM335 pKK223–3 0 7.8
pACYC184 0 5.4
JM109/pGR2 pACYC184 2.2  103 3.4  104
WM335/pGR2 pACYC184 0.8  102 6.6  102
a Fifteen ng of the DNA was used for the transformation experiment.
b An E. coli transformation method with CaCl2; Sambrook et al. (12).
c An E. coli transformation method with polyethylene glycol; Chung et
al. (13).
FIG. 2. Effects of the enforced production of glutamate race-
mase on the DNA supercoiling activity in E. coli cells. A, the DNA
supercoiling activity of each E. coli JM109 clone harboring pKK223-3,
pGR2, or pGR3. B, the DNA supercoiling activity of each E. coli WM335
clone harboring pKK223-3, pGR2, or pGR3. These E. coli clones were
cultivated at 37 °C in 100 ml of the D-glutamate-LB broth containing
Amp (50 g/ml) and IPTG (1 mM) until the turbidity at 600 nm of the
culture broth reached 2.1. Cell extracts (0.5 ml) were prepared by the
use of lysozyme (0.3%), Brij-52 (1%), and streptomycin (2%) and dia-
lyzed against TED buffer (pH 7.5) containing 1% glycerol (9). The
dialyzed sample (10 g of protein) was added to the DNA gyrase assay
mixture (see “Experimental Procedures”). Data are representative as
means  S.E. of four independent experiments.
FIG. 3. Dose-dependent inhibition of DNA gyrase by glutamate
racemase. A, titration of DNA gyrase with glutamate racemase. E. coli
GyrAB (20 nM) was incubated at 37 °C for 10 min in the DNA gyrase
assay mixture (20 l) containing various concentrations (0–50 nM) of E.
coli MurI (open circles), E. coli MurI plus UDP-MurNAc-L-Ala (10 M)
(closed circles), E. coli MurI plus D-glutamate (50 mM) (open triangles),
E. coli MurI plus L-glutamate (50 mM) (open squares), or bovine serum
albumin plus UDP-MurNAc-L-Ala (open diamonds). B, determination of
the Ki(app) value of glutamate racemase against DNA gyrase. A low
concentration of E. coli GyrAB (0.5 nM) was incubated at 37 °C for 2 h
with various concentrations (0–125 nM) of E. coli MurI and UDP-
MurNAc-L-Ala in the same assay mixture as A. During the DNA gyrase
reaction, both the supercoiled DNA products thus formed and the re-
laxed DNA substrate thus exhausted were determined densitometri-
cally (see “Experimental Procedures”).
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metabolism and growth of bacterial cells, our observations show
that an active form of glutamate racemase itself but not its
reaction product, i.e. D-glutamate, is required for the inhibition of
DNA gyrase, a most crucial enzyme in bacterial cell homeostasis.
Unlike usual amino acid racemases, glutamate racemase
contains no coenzymes such as PLP (3). There is no sequence
homology between glutamate racemase and usual amino acid
racemases (6). The catalytic efficiency of glutamate racemase is
exceedingly low compared with those of PLP-dependent amino
acid racemases (5). Interestingly, the orthologues of glutamate
racemase have been found from various organisms, including
peptidoglycan-less organisms such as archaea, plants, and hu-
mans (19). Most of these proteins, however, have not been
characterized yet because of their loss of function as glutamate
racemase. It was recently reported that the glutamate race-
mase orthologue-encoding gene was expressed to excess in hu-
man carcinoma (19), in which abnormal DNA replication fre-
quently took place during cell division. On the other hand,
among other PLP-independent amino acid racemases, the pro-
line racemase from Trypanosoma cruzi was found to exhibit the
function as an immune B-cell mitogen (20). Some PLP-inde-
pendent amino acid racemases including glutamate racemase
have possibly evolved from ancient proteins that had not been
originally involved in amino acid metabolism. It remains to be
investigated whether glutamate racemase-like proteins sub-
stantially modulate DNA topoisomerases, as their detailed
structural analyses could provide insights into the molecular
evolution of D-amino acid-metabolic enzymes, deepen the un-
derstanding of the mechanism of cell division, and result in the
design of novel pharmaceuticals.
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